Stifel Financial
HQL

Stifel Financial’s abrdn Life Sciences Investors HQL Stock Holding History

Stifel Financial’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$656K Sell
40,306
-1,360
-3% -$22.7K ﹤0.01% 2700
2025
Q4 		$699K Buy
41,666
+20,437
+96% +$343K ﹤0.01% 2675
2025
Q3 		$329K Buy
21,229
+250
+1% +$3.42K ﹤0.01% 3057
2025
Q2 		$269K Sell
20,979
-1,587
-7% -$19.6K ﹤0.01% 3109
2025
Q1 		$286K Sell
22,566
-5,775
-20% -$78.2K ﹤0.01% 2996
2024
Q4 		$372K Buy
28,341
+11,378
+67% +$164K ﹤0.01% 2859
2024
Q3 		$256K Sell
16,963
-2,750
-14% -$41.6K ﹤0.01% 3032
2024
Q2 		$279K Sell
19,713
-4,528
-19% -$61.2K ﹤0.01% 2949
2024
Q1 		$330K Sell
24,241
-4,125
-15% -$57.1K ﹤0.01% 2859
2023
Q4 		$382K Sell
28,366
-21,450
-43% -$264K ﹤0.01% 2711
2023
Q3 		$621K Sell
49,816
-4,110
-8% -$54.1K ﹤0.01% 2376
2023
Q2 		$730K Sell
53,926
-4,500
-8% -$62.1K ﹤0.01% 2286
2023
Q1 		$814K Sell
58,426
-18,288
-24% -$261K ﹤0.01% 2194
2022
Q4 		$1.09M Buy
76,714
+2,703
+4% +$39.2K ﹤0.01% 1932
2022
Q3 		$1.01M Sell
74,011
-620
-0.8% -$9.27K ﹤0.01% 1963
2022
Q2 		$1.06M Buy
74,631
+194
+0.3% +$2.93K ﹤0.01% 1949
2022
Q1 		$1.23M Buy
74,437
+988
+1% +$17K ﹤0.01% 1955
2021
Q4 		$1.41M Buy
73,449
+661
+0.9% +$13.3K ﹤0.01% 1865
2021
Q3 		$1.51M Sell
72,788
-564
-0.8% -$12.1K ﹤0.01% 1772
2021
Q2 		$1.57M Sell
73,352
-1,552
-2% -$31.3K ﹤0.01% 1777
2021
Q1 		$1.48M Sell
74,904
-14,591
-16% -$301K ﹤0.01% 1714
2020
Q4 		$1.77M Buy
89,495
+71,751
+404% +$1.33M ﹤0.01% 1460
2020
Q3 		$312K Sell
17,744
-783
-4% -$14K ﹤0.01% 2371
2020
Q2 		$332K Sell
18,527
-2,419
-12% -$41.5K ﹤0.01% 2288
2020
Q1 		$313K Buy
20,946
+3,267
+18% +$53.5K ﹤0.01% 2154
2019
Q4 		$308K Sell
17,679
-123
-0.7% -$2.02K ﹤0.01% 2520
2019
Q3 		$269K Buy
17,802
+500
+3% +$8.01K ﹤0.01% 2503
2019
Q2 		$291K Sell
17,302
-451
-3% -$7.43K ﹤0.01% 2518
2019
Q1 		$304K Buy
17,753
+232
+1% +$4K ﹤0.01% 2348
2018
Q4 		$265K Sell
17,521
-10,298
-37% -$181K ﹤0.01% 2301
2018
Q3 		$569K Buy
27,819
+1,039
+4% +$20.7K ﹤0.01% 2026
2018
Q2 		$503K Sell
26,780
-1,069
-4% -$20.1K ﹤0.01% 2031
2018
Q1 		$533K Buy
27,849
+11,512
+70% +$231K ﹤0.01% 1937
2017
Q4 		$321K Sell
16,337
-5,660
-26% -$113K ﹤0.01% 2158
2017
Q3 		$474K Sell
21,997
-5,219
-19% -$111K ﹤0.01% 1909
2017
Q2 		$573K Buy
27,216
+1,327
+5% +$26.8K ﹤0.01% 1796
2017
Q1 		$506K Sell
25,889
-16,642
-39% -$308K ﹤0.01% 1805
2016
Q4 		$708K Sell
42,531
-15,399
-27% -$270K ﹤0.01% 1587
2016
Q3 		$1.09M Sell
57,930
-11,803
-17% -$222K ﹤0.01% 1280
2016
Q2 		$1.2M Buy
+69,733
New +$1.29M 0.01% 1238
2015
Q1 		– Sell
-11,700
Closed -$291K – 2348
2014
Q4 		$291K Hold
11,700
– – ﹤0.01% 1896
2014
Q3 		$259K Sell
11,700
-350
-3% -$7.6K ﹤0.01% 1873
2014
Q2 		$250K Buy
+12,050
New +$253K ﹤0.01% 1879

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Stifel Financial's HQL Position: Q1 2026 in Review

Stifel Financial reduced its abrdn Life Sciences Investors (HQL) stake by 3.3% in Q1 2026, selling an estimated $22.7K and leaving 40,306 shares worth $656K. The position accounts for ﹤0.01% of the portfolio, ranked #2700.

Stifel Financial first reported a position in HQL in Q2 2014 and has held it in 43 quarters since. The position peaked at $1.77M in Q4 2020. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

  • Stifel Financial held 40,306 shares of abrdn Life Sciences Investors worth $656K as of Q1 2026.
  • Stifel Financial sold 1,360 abrdn Life Sciences Investors shares in Q1 2026, an estimated $22.7K.
  • abrdn Life Sciences Investors made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #2700 holding.
  • Stifel Financial first reported a position in abrdn Life Sciences Investors in Q2 2014 and has held it in 43 quarters since.
  • Stifel Financial's abrdn Life Sciences Investors position peaked at $1.77M in Q4 2020.
  • 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.